Hydrolysis of peripheral leucine enkephalin in allergic asthma

Clinical Immunology

Volumn 90, Issue 3, 1999, Pages 411-419

  Fuso, Lionello ^a   Marini, Mario ^b   Marzano, Marina ^b   Nardecchia, Bernardino ^b   Roda, L Giorgio ^b   Rossi, Paolo ^b   Urbani, Alessandra ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Allergy; Asthma; Enzyme inhibitors; Opioid peptides; Plasma proteolysis

Indexed keywords

LEUCINE ENKEPHALIN; NEUROPEPTIDE; PROTEINASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0032924558     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4667     Document Type: Article

References (51)

1. Tobin, D., Nabarro, G., Baart de la Faille, H., van Vloten, W. A., van der Putte, S. C. J., and Schuurman, H.-J., Increased number of immunoreactive nerve fibers in atopic dermatitis. J. Allergy Clin. Immunol. 90, 613-619, 1992.
2. Foreman, J. C., Neuropeptides and the pathogenesis of allergy. Allergy 42, 1-11, 1987.
3. Barnes, P. J., Neuropeptides in the lung: Localization, function and pathophysiological implications. J. Allergy Clin. Immunol. 79, 285-295, 1987.
4. Nieber, K., Baumgarten, C. R., Rathsak, R., Furkert, L., Oehme, P., and Kunkel, G., Substance P and beta-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90, 646-654, 1992.
5. Tciramaa, E., Psychosocial and psychic factors at onset of asthma. J. Psychosomatic Res. 23, 27-37, 1979.
6. Llorens, C., and Schwartz, J.-C., Enkephalinase activity in rat peripheral organs. Eur. J. Pharmacol. 69, 113-1166, 1981.
7. Johnson, A. R., Aston, J., Schultz, W. W., and Erdös, E. G., Neutral metalloendopeptidase in human lung tissue and cultured cells. Am. J. Respir. Dis. 132, 564-568, 1985.
8. Bellofiore, S., Caltagirone, F., Pennisi, A., Ciancio, N., Mistretta, A., and Di Maria, G. U., Neutral endopeptidase inhibitor thiorphan increases airway narrowing to inhaled sodium metabisulfite in normal subjects. Am. J. Respir. Crit. Care Med. 150, 853-856, 1994.
9. De Gouw, H. W. F. M., Diamant, Z., Kuijpers, E. A. P., Sont, J. K., and Sterk, P. J., Role of neutral endopeptidase in exercise-induced bronchoconstriction in asthmatic subjects. J. Appl. Physiol. 81, 673-678, 1996.
10. Angus, R. M., McCallum, M. J. A., Nally, J. E., and Thomson, N. C., No effect of the oral neutral endopeptidase inhibitor candoxatril on bronchomotor tone and histamine reactivity in asthma. Eur. Respir. J. 7, 1084-1089, 1994.
11. Jacoby, D. B., Tamaoky, J., Borson, D. B., and Nadel, J. A., Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase. J. Appl. Physiol. 64, 2653-2658, 1988.
12. Saban, R., Dick, E. C., Fishleder, R. I., and Buchner, C. K., Enhancement of parainfluenza 3 infection of contractile responses to substance P and capsaicin in airway smooth muscle from the guinea pig. Am. Rev. Respir. Dis. 136, 586-591, 1987.
13. Niehus, J., Ratti, H., Zhang, M., Lucas, C., and Kunkel, G., Correlation between neutral endopeptidase (NEP 3.4. 24.11) in serum and bronchial reactivity to acetylcholine. J. Pharm. Ther. 3, 59-64, 1994.
14. Carr, D. J. J., and Serou, M., Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31, 59-71, 1995.
15. Roda, L. G., Bongiorno, L., Trani, E., Urbani, A., and Marini, M., Positive and negative immunomodulation by opioid peptides. Int. J. Immunopharmacol. 18, 1-16, 1996.
16. Plotnikoff, N. P., Faith, R. E., Murgo, A. J., Herberman, R. B., and Good, R. A., Methionine enkephalin: A new cytokine -human studies. Clin. Immunol. Immunopathol. 82, 93-101, 1997.
17. Bowes, M. A., and Kenny, A. J., An immunohistochemical study of endopeptidase-24.11 and aminopeptidase N in lymphoid tissues. Immunology 60, 247-253, 1987.
18. Marini, M., Urbani, A., Bongiorno, L., and Roda, L. G., Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines, III: Soluble enzymes. Int. J. Immunopharmacol. 14, 995-1002, 1992.
19. Connelly, J. C., Skidgel, R. A., Schultz, W. W., Johnson, A. R., and Erdos, E. G., Neutral endopeptidase 24.11 in human neutrophils: Cleavage of chemotactic peptide. Proc. Natl. Acad. Sci. USA 82, 8737-8741, 1985.
20. Pierart, M. E., Najdovski, T., Appelboom, T. E., and Deschodt-Lanckman, M. M., Effect of human endopeptidase 24.11 ("enkephalinase") on IL-1-induced thymocyte proliferation activity. J. Immunol. 140, 3808-3811, 1988.
21. Drapeau, G., Chow, A., and Ward, P. E., Metabolism of bradikinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides 12, 631-638, 1991.
22. Venturelli, F., Roscetti, G., Laugesen, G., Gilardi, E., Barra, P. F. A., and Roda, L. G., Control mechanisms of peripheral enkephalin hydrolysis in mammalian plasma. Comp. Biochem. Physiol. 85(c), 307-311, 1986.
23. Bolacchi, F., Marini, M., Urbani, A., and Roda, L. G., Enzymes and inhibitors of leu-enkephalin metabolism in human plasma. Neurochem. Res. 20, 991-999, 1995.
24. Chipkin, R. E., and Coffin, V. L., Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615. Pharmacol. Biochem. Behav. 38, 21-27, 1991.
25. Saksida, L. M., Galea, L. A. M., and Kavaliers, M., Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides 14, 763-765, 1993.
26. Nabeshima, T., Katoh, A., and Kameyama, T., Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). J. Pharmacol. Exp. Ther. 244, 303-309, 1988.
27. Daugé, V., Mauborgne, A., Casselin, F., Fournié-Zalusky, M.-C., and Roques, B.-P., The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of met-enkephalin-like material in the nucleus accumbens of freely moving rats. J. Neurochem. 67, 1301-1308, 1996.
28. 3H]β-endorphin in rat plasma is increased with chronic stress. Eur. J. Pharmacol. 16, 229-236, 1989.
29. Katoh, A., Nabeshima, T., and Kameyama, T., Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. J. Pharmacol. Exp. Ther. 253, 600-607, 1990.
30. Schulteis, G., and Martinez, J. L., Jr., Experience-dependent regulation of leu-enkephalin hydrolysis in rat plasma. Peptides 14, 161-167, 1993.
31. Ader, R., Behaviorally conditioned immunosuppression. Psychosom. Med. 37, 333-340, 1975.
32. Plotnikoff, N. P., Takemori, A. E., and Portoghese, P. S., Enkephalin-endorphins: Emotional stress, depression and the immune system. Psycopharmacol. Bull. 21, 464-465, 1985.
33. Roscetti, G., Possenti, R., Bassano, E., and Roda, L. G., Mechanisms of leu-enkephalin hydrolysis in human blood. Neurochem. Res. 10, 1393-1404, 1985.
34. Marini, M., Urbani, A., Bongiorno, L., and Roda, L. G., Interin-dividual variability of enkephalin-degrading enzymes in human plasma. Peptides 18, 741-748, 1997.
35. Schwartz, J. C., Malfroy, B., and De La Baume, S., Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci. 29, 1715-1740, 1981.
36. MacKenzie, J. N., The production of the so-called "rose cold" by means of an artificial rose. Am. J. Med. Sci. 91, 45-57, 1886.
37. Smith, G. H., and Salinger, R., Hypersensitiveness and the conditioned reflex. Yale J. Biol. Med. 5, 387-402, 1933.
38. Russell, M., Dark, K. A., Cummings, R. W., Ellman, G., Callaway, E., and Peeke, H. V. S., Learned histamine release. Science 225, 733-734, 1984.
39. MacQueen, G. M., Marshall, J., Perdue, M., Siegel, S., and Bienenstock, J., Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 243, 83-85, 1989.
40. Schleifer, S. J., Keller, S. E., and Stein, M., Brain, behaviour and the immune system. Nature 310, 456, 1984.
41. Laudenslager, M. L., Ryan, S. M., Drugan, R. C., Hyson, R. L., and Maier, S. F., Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221, 568-570, 1983.
42. Sacerdote, P., Manfredi, B., Bianchi, M., and Panerai, A. E., Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav. Immun. 8, 251-260, 1994.
43. Goetzl, E. J., Adelman, D. C., and Sreedharan, S. P., Neuroimmunology. Adv. Immunol. 48, 161-190, 1990.
44. Smith, E. M., and Blalock, J. E., Human leucocyte production of corticotropin and endorphin-like substances: Association with leucocyte interferon. Proc. Natl. Acad. Sci. USA 78, 7530-7534, 1981.
45. Kavelaars, A., Ballieux, R. E., and Heijnen, C. J., The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive β-endorphin by human peripheral blood mononuclear cells. J. Immunol. 142, 2338-2342, 1989.
46. Viveros, O. H., Diliberto, E. J., Hazum, E., and Chang, K. J., Opiate like material in the adrenal medulla. Evidence for storage and secretion with catecholamines. Mol. Pharmacol. 16, 1101-1108, 1979.
47. Janak, P. H., Manly, J. J., and Martinez, J. L., [Leu] enkephalin enhances active avoidance conditioning in rat and mice. Neuropsychopharmacology 10, 53-60, 1994.
48. Venturelli, F., Roscetti, G., Possenti, R., Vita, F., and Roda, L. G., Peripheral enkephalin hydrolysis in different animal species: a comparative study. Neurochem. Res. 10, 333-342, 1985.
49. Shavit, Y., Lewis, J. W., Terman, G. W., Gale, R. P., and Liebeskind, J. C., Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223, 188-190, 1984.
50. Roscetti, G., Venturelli, F., and Roda, L. G., Enkephalin-binding systems in human plasma III: Comparative protection of different peptides. Neurochem. Res. 13, 221-224, 1988.
51. Caughey, G. H., Leidig, F., Viro, N. F., and Nadel, J. A., Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 244, 133-137, 1988.